NCT00654082 - A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

August 31, 2003

Conditions

Spinal Cord InjuryErectile DysfunctionSpinal Cord TraumaInjuries, Spinal CordImpotence

Interventions

DRUG

sildenafil

sildenafil 50 mg tablet by mouth 1 hour prior to anticipated sexual activity, but not more than once daily (QD) for 6 weeks; after 2 weeks on treatment, doses could be escalated to 100 mg or reduced to 25 mg

DRUG

placebo

placebo tablet by mouth 1 hour prior to anticipated sexual activity, but not more than once daily (QD) for 6 weeks

Trial Locations (5)

34580

Pfizer Investigational Site, Bahçelievler

Unknown

Pfizer Investigational Site, Balçova

Pfizer Investigational Site, Ankara

Pfizer Investigational Site, Bursa

Pfizer Investigational Site, Konya

All Listed Sponsors

lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY